| Product Code: ETC7648005 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Chronic Eye Diseases Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Chronic Eye Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Chronic Eye Diseases Market - Industry Life Cycle |
3.4 Israel Chronic Eye Diseases Market - Porter's Five Forces |
3.5 Israel Chronic Eye Diseases Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Chronic Eye Diseases Market Revenues & Volume Share, By Medication, 2021 & 2031F |
3.7 Israel Chronic Eye Diseases Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Israel Chronic Eye Diseases Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Chronic Eye Diseases Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Chronic Eye Diseases Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Chronic Eye Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic eye diseases in Israel due to factors such as aging population and lifestyle changes |
4.2.2 Technological advancements in diagnostic tools and treatment options for chronic eye diseases |
4.2.3 Growing awareness and emphasis on early detection and management of eye diseases in Israel |
4.3 Market Restraints |
4.3.1 High cost of advanced treatment options and medications for chronic eye diseases |
4.3.2 Limited access to specialized eye care services in certain regions of Israel |
4.3.3 Regulatory challenges and strict approval processes for new eye disease treatments in the market |
5 Israel Chronic Eye Diseases Market Trends |
6 Israel Chronic Eye Diseases Market, By Types |
6.1 Israel Chronic Eye Diseases Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Chronic Eye Diseases Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Chronic Eye Diseases Market Revenues & Volume, By Diabetic and Hypertensive Retinopathy, 2021- 2031F |
6.1.4 Israel Chronic Eye Diseases Market Revenues & Volume, By Cataracts, 2021- 2031F |
6.1.5 Israel Chronic Eye Diseases Market Revenues & Volume, By Age-Related Macular Degeneration (AMD), 2021- 2031F |
6.1.6 Israel Chronic Eye Diseases Market Revenues & Volume, By Thyroid Ophthalmopathy (Graves Disease), 2021- 2031F |
6.1.7 Israel Chronic Eye Diseases Market Revenues & Volume, By Glaucoma Dry Eye, 2021- 2031F |
6.1.8 Israel Chronic Eye Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Chronic Eye Diseases Market, By Medication |
6.2.1 Overview and Analysis |
6.2.2 Israel Chronic Eye Diseases Market Revenues & Volume, By Anti-inflammatory, 2021- 2031F |
6.2.3 Israel Chronic Eye Diseases Market Revenues & Volume, By Anti-glaucoma, 2021- 2031F |
6.2.4 Israel Chronic Eye Diseases Market Revenues & Volume, By Lubricating Agents, 2021- 2031F |
6.2.5 Israel Chronic Eye Diseases Market Revenues & Volume, By Immunosuppressive, 2021- 2031F |
6.2.6 Israel Chronic Eye Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Chronic Eye Diseases Market, By Product Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Chronic Eye Diseases Market Revenues & Volume, By Eye Drops, 2021- 2031F |
6.3.3 Israel Chronic Eye Diseases Market Revenues & Volume, By Eye Ointment, 2021- 2031F |
6.3.4 Israel Chronic Eye Diseases Market Revenues & Volume, By Gel, 2021- 2031F |
6.3.5 Israel Chronic Eye Diseases Market Revenues & Volume, By Liquid Wipes, 2021- 2031F |
6.3.6 Israel Chronic Eye Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Chronic Eye Diseases Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Chronic Eye Diseases Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Chronic Eye Diseases Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Israel Chronic Eye Diseases Market Revenues & Volume, By Ocular, 2021- 2031F |
6.4.5 Israel Chronic Eye Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Chronic Eye Diseases Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Chronic Eye Diseases Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Chronic Eye Diseases Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Israel Chronic Eye Diseases Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Israel Chronic Eye Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Chronic Eye Diseases Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Chronic Eye Diseases Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Chronic Eye Diseases Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Chronic Eye Diseases Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Israel Chronic Eye Diseases Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Chronic Eye Diseases Market Import-Export Trade Statistics |
7.1 Israel Chronic Eye Diseases Market Export to Major Countries |
7.2 Israel Chronic Eye Diseases Market Imports from Major Countries |
8 Israel Chronic Eye Diseases Market Key Performance Indicators |
8.1 Number of ophthalmologists per capita in Israel |
8.2 Percentage of population undergoing regular eye screenings |
8.3 Adoption rate of advanced diagnostic tools and treatments for chronic eye diseases |
9 Israel Chronic Eye Diseases Market - Opportunity Assessment |
9.1 Israel Chronic Eye Diseases Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Chronic Eye Diseases Market Opportunity Assessment, By Medication, 2021 & 2031F |
9.3 Israel Chronic Eye Diseases Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.4 Israel Chronic Eye Diseases Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Chronic Eye Diseases Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Chronic Eye Diseases Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Chronic Eye Diseases Market - Competitive Landscape |
10.1 Israel Chronic Eye Diseases Market Revenue Share, By Companies, 2024 |
10.2 Israel Chronic Eye Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here